Imperial College London
Portrait Picture

DrJonathanKrell

Faculty of Medicine, Department of Surgery & Cancer

Clinical SL in Medical Oncology (Gynaecological Oncology)
 
 
 
//

Contact

 

j.krell

 
 
//

Location

 

Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Scambia:2020,
author = {Scambia, G and Han, SN and Oza, AM and Colombo, N and Oaknin, A and Raspagliesi, F and Wenham, RM and Braicu, EI and Jewell, A and Makker, V and Guerra, EM and Moxley, KM and Baurain, J-F and Su, Z and Neuwirth, R and Vincent, S and Sedarati, F and Faller, D and Krell, J},
publisher = {AMER SOC CLINICAL ONCOLOGY},
title = {Randomized phase II study of sapanisertib (SAP) plus paclitaxel (PAC) versus PAC alone in patients (pts) with advanced, recurrent, or persistent endometrial cancer.},
url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368303002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202},
year = {2020}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Scambia,G
AU  - Han,SN
AU  - Oza,AM
AU  - Colombo,N
AU  - Oaknin,A
AU  - Raspagliesi,F
AU  - Wenham,RM
AU  - Braicu,EI
AU  - Jewell,A
AU  - Makker,V
AU  - Guerra,EM
AU  - Moxley,KM
AU  - Baurain,J-F
AU  - Su,Z
AU  - Neuwirth,R
AU  - Vincent,S
AU  - Sedarati,F
AU  - Faller,D
AU  - Krell,J
PB  - AMER SOC CLINICAL ONCOLOGY
PY  - 2020///
SN  - 0732-183X
TI  - Randomized phase II study of sapanisertib (SAP) plus paclitaxel (PAC) versus PAC alone in patients (pts) with advanced, recurrent, or persistent endometrial cancer.
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368303002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER  -
Download